Position in XERS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,155,662
+$441,195 QoQ
Shares Held
145,917
+18.5% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#81
of 238 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GLOBEFLEX CAPITAL L P holds $37,103,577 across 12 Drug Manufacturers - Specialty & Generic names. XERS ranks #10 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIP |
Ani Pharmaceuticals Inc
|
108,569 | $8,987,341 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
93,396 | $5,972,674 | |
| 3 | PAHC |
Phibro Animal Health Corp
|
189,224 | $5,941,633 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
28,363 | $4,780,300 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
146,508 | $2,536,053 | |
| 6 | EBS |
Emergent BioSolutions Inc.
|
241,298 | $2,022,077 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
52,911 | $1,915,378 | |
| 8 | ANIK |
Anika Therapeutics, Inc.
|
87,600 | $1,281,588 |
All Filings in XERS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,155,662 | 145,917 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $714,467 | 123,184 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $966,994 | 123,184 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,002,717 | 123,184 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $375,612 | 80,431 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $687,402 | 125,210 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $424,461 | 125,210 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||